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Objective: Circulating ANGPTL8 has recently been used as a marker of insulin action. We studied
expression and insulin regulation of ANGPTL8 and ANGPTL3 in vivo and in vitro.
Design and Methods: Expression of ANGPTL8 and ANGPTL3 was studied in 34 paired samples of
human liver and adipose tissue. Effects of insulin on 1) plasma concentrations and adipose tissue
expression of ANGPTL8 and ANGPTL3 (in vivo 6-h euglycemic hyperinsulinemia; n  18), and 2)
ANGPTL8 and ANGPTL3 gene and protein expression in immortalized human hepatocytes (IHH)
and adipocytes were measured. Effect of ANGPTL3 on secretion of ANGPTL8 in cells stably over-
expressing ANGPTL3, -8, or both was determined.
Results:ANGPTL3was only expressed in the liver, whereasANGPTL8was expressed in both tissues.
In vivo hyperinsulinemia significantly decreased both plasma ANGPTL8 and ANGPTL3 at 3 and 6
hours. Insulin increased ANGPTL8 expression in human adipose tissue 14- and 18-fold at 3 and 6
hours andANGPTL8was themost insulin-responsive transcriptonmicroarray. Insulinalso increased
ANPGTL8 in cultured adipocytes and IHH but the protein mainly remained intracellular. In vitro in
IHH, insulin decreasedANGPTL3 gene expression and secretion of ANGPTL3 into growthmedium.
Overexpression of ANGPTL8 in CHO cells did not result in its release into culture medium while
abundant secretion occurred in cells co-expressing ANGPTL3 and -8.
Conclusions: Insulin decreases plasma ANGPTL3 by decreasing ANGPTL3 expression in the liver.
Insulin markedly increases ANGPTL8 in adipose tissue and the liver but not in plasma. These data
showthatmeasurementofplasmaANGPTL3butnot -8 reflects insulinaction in target tissues. (JClin
Endocrinol Metab 100: E1299–E1307, 2015)
Insulin decreases circulating triglycerides (TGs) by inhib-iting adipose tissue lipolysis, very low-density lipopro-
tein production from the liver, and by stimulating intra-
vascular lipolysis of TG-rich lipoproteins in peripheral
tissues (1). Angiopoietin-like proteins (ANGPTLs), par-
ticularly ANGPTL3, -8 and -4, play a major role in TG
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trafficking and mediate at least some of the effects of in-
sulin (2). Of these, insulin regulation of ANGPTL4 has
been best studied. In humans, in vivo hyperinsulinemia
decreases circulating ANGPTL4 (3, 4). In vitro, insulin
down-regulates the Angptl4mRNA in 3T3-L1 adipocytes
(5) and mRNA and protein concentrations in human
hepatocytes (4), likely via the transcription factor FoxO1
(6). Mice lacking Angptl4 (7) and humans carrying se-
quence variants ofANGPTL4, which interferewith either
production or secretion of the protein or its ability to in-
hibit lipoprotein lipase, have reduced levels of TGs (8).
ANGPTL8, also known as betatrophin, TD26, hepa-
tocellular carcinoma–associated gene, c19orf80, refeed-
ing-induced fat and liver (9, 10), and lipasin (11), is a
recently identified member of the ANGPTL gene family,
which is expressed in adipose tissue and the liver and
found in humanplasma (12). ANGPTL8 is involved inTG
storage in adipose tissue given that Angptl8 knockout
mice gain less fat than wild-type mice (13), and siRNA-
mediated knockdown of this protein decreases the TG
content of 3T3-L1 adipocytes (9). Insulin markedly in-
creases ANGPTL8 expression in 3T3-L1 adipocytes but
the protein is not secreted into the culture medium (9). In
mouse liver, the Angptl8 transcript increases markedly in
response to refeeding (9, 12) but data regarding insulin
regulation of plasma ANGPTL8 protein concentrations
are lacking, and it is unknownwhether plasmaANGPTL8
concentration reflects insulin action in human adipose tis-
sue. This knowledge would seem to be of interest given
that several recent studies have suggested plasma ANG-
PTL8 as a marker of insulin resistance (14–18).
ANGPTL3 is mainly expressed in the liver in humans
(8). Treatmentwith recombinantANGPTL3 increases cir-
culating TGs (19), and ANGPTL3 inhibits activities of
both lipoprotein lipase and endothelial lipase (20, 21) in
vitro. In humans, loss-of-function mutations of ANG-
PTL3 are associatedwith decreases in TG, low-, and high-
density lipoprotein (22). Insulin decreases ANGPTL3
mRNAandprotein in humanhepatomaHepG2 cells (23).
However, there are no data on in vivo effects of insulin on
circulating ANGPTL3 in humans.
Secretion of ANGPTL3 and -8 may be mechanistically
interdependent given that coexpression of the two pro-
teins in the liver of mice decreases circulating ANGPTL3
compared with expression of ANGPTL3 alone (12). In
HepG2 cells coexpression of ANGPTL3 and -8 increases
ANGPTL8 protein secretion to culture media compared
with expression of ANGPTL8 alone, suggesting that
ANGPTL8 secretion might depend on ANGPTL3 (12).
In the present study we 1) compared expression of
ANGPTL3, -8, and -4 in liver and adipose tissue samples
from the same subjects; 2) determined effects of in vivo
euglycemic hyperinsulinemia on circulating concentra-
tions of ANGPTL3, -8, and -4, and on expression of the
respective genes in human adipose tissue biopsies; 3) ex-
amined how insulin regulatesANGPTL3 and -8 gene and
protein expression in cells and culture media of IHH and
cultured adipocytes; and 4) determined in Chinese ham-
ster ovary (CHO) cells whether ANGPTL8 secretion de-
pends on ANGPTL3.
Study Design and Methods
Expression of ANGPTL3, -8, and -4 in human liver
and adipose tissue
Subjects
We recruited 34 subjects undergoing laparoscopic gastric by-
pass surgery. The inclusion criteria were 1) age 18–65 years; 2)
no known acute or chronic disease except for obesity based on
history, physical examination, and standard laboratory tests
(blood counts, serum creatinine, electrolyte concentrations, and
electrocardiogram); and 3) alcohol consumption less than 20 g
per day. During theweek preceding surgery, blood samples were
taken after an overnight fast for measuring plasma glucose, se-
rum insulin, liver enzyme, serum TG, and total and high-density
lipoprotein cholesterol concentrations as described (24). At the
time of surgery, wedge biopsies of the liver and sc adipose tissue
were obtained. One half of the liver biopsy specimen was sent to
the pathologist for histopathological assessment, and the rest
was immediately frozen in liquid N2. Triglyceride content (per-
centage of hepatocytes with macrovesicular and microvesicular
steatosis), stage, grade, andpresenceofnecroinflammation in the
liver biopsies were determined under light microscope by a liver
pathologist in a blinded fashion (25). Characteristics of the hu-
man subjects studied are summarized in Supplemental Table 1.
Quantification of ANGPTL3, -8, and -4 mRNA
concentrations
ANGPTL3, -8, and -4 gene expressions were determined in
the liver and adipose tissue biopsies by qPCR. Total RNA was
isolated with the RNeasy Mini Kit (QIAGEN) according to the
manufacturer’s protocol. Reverse transcription was performed
using Moloney murine leukemia virus (M-MLV) reverse tran-
scriptase (Invitrogen) and oligo(dT) priming. Power SYBR
Green PCR Master Mix and Light Cycler 480 II (Roche Diag-
nostics) were used for qPCR analysis. Data were normalized to
the mRNA of acidic ribosomal phosphoprotein 36B4. Primer
sequences are shown in Supplemental Table 2.
Effects of insulin on plasma ANGPTLs and gene
expression in adipose tissue in vivo in humans
Subjects
A total of 18 nondiabetic Caucasian women were recruited
based on the following inclusion criteria: 1) age 18–60 years; 2)
no known acute or chronic disease other than obesity based on
history, physical examination and standard laboratory tests
(blood counts, serum creatinine, electrolyte concentrations, and
electrocardiogram); and 3) body mass index less than 40 kg/m2.
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Exclusion criteria included pregnancy or treatment with drugs
that may alter glucose tolerance.
Whole-body insulin sensitivity and effect of insulin
on plasma ANGPTL3, -8, and -4 concentrations and
ANGPTL4 and -8 gene expression in adipose tissue in
vivo
Whole-body insulin sensitivity was measured using the eu-
glycemic hyperinsulinemic clamp technique, as previously de-
scribed (26). After an overnight fast, two 18-gauge catheters
(Venflon; Viggo-Spectramed) were inserted, one in the antecu-
bital vein for insulin and20%glucose infusion (InsulinActrapid;
Novo Nordisk), and another retrogradely in a heated hand vein
to sample arterialized venous blood. The rate andduration of the
continuous insulin infusionwere1mU/kgperminute for6hours.
Normoglycemia was maintained by adjusting the rate of 20%
glucose infusion based on plasma glucose measurements, from
the arterialized venous blood collected every 5 minutes. Whole-
body insulin sensitivity was determined from the glucose infu-
sion rate required to maintain normoglycemia between 30 and
360 minutes. Blood samples were collected at 0, 3, and 6 hours
for measuring plasma ANGPTL3, -8, and -4 concentrations.
Needle aspiration biopsies of sc adipose tissue were taken before
and after 3 and 6 hours of hyperinsulinemia for measurement of
ANGPTL8 and -4 expression. The qPCR was performed as de-
scribed above, using a geometricmeanof the housekeeping genes
36B4 and -actin as reference.ANGPTL3was not expressed in
adipose tissue.
To compare the insulin responsiveness ofANGPTL8 to other
genes in the human adipose tissue transcriptome, we reanalyzed
previously reported microarray data deposited in the GEO da-
tabase (GSE26637) (27). The microarrays were performed on
RNA isolated from adipose tissue biopsies obtained at 0 and 3
hours of in vivo hyperinsulinemia (27). The fold change in gene
expression was calculated and 100 genes showing the highest
increase were selected for statistical analysis. Significances were
evaluated using the Student t test and by applying Benjamini-
Hochberg multiple-test correction.
The nature and potential risks of the above two studies were
explained toall subjects prior toobtaining theirwritten informed
consent. The study was carried out in accordance with the dec-
laration of Helsinki. The protocols were approved by the Me-
dicinal Ethics Committee of the Helsinki and Uusimaa Hospital
District.
Plasma concentrations of ANGPTLs
PlasmaANGPTL3 andANGPTL4 concentrationsweremea-
sured by in-house ELISAs,which have been previously described
and validated to be specific, not cross reacting with each others’
antigens (28). Plasma ANGPTL8 concentrations were deter-
mined using an ELISA (Aviscera Bioscience, Catalog No.
SK00528–02) according to the manufacturer’s protocol. Each
assay included an ANGPTL8 control sample supplied with the
ELISA kit. The interassay and intra-assay coefficients of varia-
tion were 13% and 7%. The ANGPTL8 ELISA assay did not
cross react with ANGPTL3 or -4. Western blot analysis of
plasma ANGPTL8 in plasma samples taken before and after 3
and 6 hours of hyperinsulinemia was carried out at the Depart-
ment of Internal Medicine, University of Texas Southwestern
Medical Center, Dallas, TX, by using a previously characterized
antibody (12).
Insulin regulation of ANGPTL3 and -8 in vitro
Cell culture
Immortalized human hepatocytes (IHH) (29) were grown on
12- or 6-well CellBIND Surface cell culture plates (Corning) in
William’s E medium (GIBCO/Life Technologies) containing
10% fetal bovine serum, 100 U/mL penicillin, 2 mmol/L L-glu-
tamine, 100 g/mL streptomycin, 50nM dexamethasone, and
100nM insulin (Sigma-Aldrich).
Simpson-Golabi-Behmel syndrome (SGBS) adipocytes re-
spond to insulin (glucose uptake) and -adrenergic stimuli (li-
polysis) and thus resemble human primary adipocytes (30).
SGBSpreadipocyteswere grownanddifferentiatedon6- and12-
well plates asdescribed (30). Briefly, cellswere grown inDMEM/
F12 containing 10% fetal bovine serum for 3 days until they
reached confluency. Differentiation was induced using serum-
and albumin-free DMEM/F12mediumwith 0.5 mmol/L methyl
iso-buthylxantine, 0.1 mol/L cortisol, and 2 mol/L rosiglita-
zone. Dexamethasone (25 nmol/L), 0.01 mg/mL transferrin, 0.2
nmol/L triiodotyronin, and 20 nmol/L human insulin (Sigma-
Aldrich) for 4 days. Thereafter, the cells were cultured for 10
days in DMEM/F12 supplemented with 0.1 mol/L cortisol,
0.01 mg/mL transferrin, 0.2 nmol/L triiodotyronin, and 20
nmol/L human insulin for complete differentiation.
Effect of insulin onANGPTL3 and -8 gene and protein
expression in IHH and SGBS cells
Differentiated SGBS cells and IHH were serum starved in
DMEM containing 5mM glucose for 24 hours and then treated
with 100nM insulin (Sigma-Aldrich) in the same medium for 24
hours. RNA or proteins were isolated after insulin treatment for
the measurement of ANGPTL3 and -8 mRNAs by qPCR and
protein levels by the ELISAs described above. For determination
of ANGPTL3 and -8 mRNA concentrations in cells, total RNA
was isolated from insulin-treated and untreated IHH and SGBS
cells using the PureLink RNA Mini Kit (Invitrogen). Reverse
transcription and qPCR for ANGPTL3 and -8 were conducted
as described above. The data were normalized to the geometric
mean of two housekeeping mRNAs, the acidic ribosomal phos-
phoprotein 36B4, and succinate dehydrogenase complex, sub-
unit A (SDHA).
For measurement of ANGPTL3 and -8 protein concentra-
tions, growthmedia and cell lysates of IHHandSGBSadipocytes
(lysed in 50mM Tris-HCl pH 7.4, 1% NP40, 0.25% sodium
deoxycholate, 150mM sodium chloride, and 1mMEDTA)were
collected after 24 hours. Themedia and cell lysates were used for
ELISA assays. As a control, adiponectin concentrations were
measured using Western blotting using an antibody against adi-
ponectin (Sigma-Aldrich; Catalog. No. A6354).
Expression of ANGPTL3 and -8 in CHO cells
The cDNAs for ANGPTL3 and ANGPTL8 preceded by the
signal sequenceofhumanalbuminwere synthesized (Genescript)
and subcloned into a proprietary mammalian expression vector
containing a CAG promoter and an IRES-pac puromycin selec-
tion marker placed after the ANGPTL open reading frame.
CHO cells were transfected with the ANGPTL3 or -8 construct
alone or both with Fugene 6 (Promega) and selected with 10–
400 ug/mL puromycin (HyClone/ThermoFisher Scientific). Af-
ter selection, the cells were adapted to suspension culture in Op-
tiCHOmedium(LifeTechnologies) supplementedwith2mmol/l
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L-alanyl-L-glutamine. Cultures were expanded at 37°C, after
which the protein was produced for 9 days at 31°C. Finally,
media and cells were collected by centrifugation and Western
blots were performed to analyze ANGPTL8 (Antibody from
GenScript) and ANGPTL3 using an in-house rabbit polyclonal
antibody.
Results
Expression of ANGPTLs in human liver and adipose
tissue
ANGPTL3 expression (qPCR) was detectable only in
the liver,whereasANGPTL8 and -4mRNAswere present
in both tissues (Figure 1, A–C). In the 34 subjects with
paired samples,ANGPTL8mRNA expression in the liver
was approximately 3.3-fold higher (P  .001) than in sc
adipose tissue (Figure 1B), whereas ANGPTL4 was less
abundantly expressed in the liver than in adipose tissue
(Figure 1C).
Effect of in vivo hyperinsulinemia on ANGPTL3, -8
and -4 concentrations in human plasma
The insulin infusion increased serum insulin concen-
trations from a fasting concentration of 42  7 to 500 
19 pmol/l (30–360 min). Plasma glucose averaged 5.3 
0.1 mmol/l in the fasting state and 5.0  0.02 mmol/L
during euglycemic hyperinsulinemia.
In vivo euglycemic hyperinsulinemia decreased both
plasma ANGPTL3 and -8 significantly, when measured
with the ELISA assays (Figure 2, A and C). Plasma ANG-
PTL3 decreased by 26% from a fasting concentration of
363 37 to 268 23 ng/mL units at 3 hours (P .001)
and by 38% to 225 24 ng/mL at 6 hours of hyperinsu-
linemia (P  .001). When measured by the ELISA, the
fasting concentration of plasma ANGPTL8 was approx-
imately 19-fold lower than that of ANGPTL3 (Figure 2B).
Plasma ANGPTL8 decreased by 17% from a fasting con-
centration of 20 4 to 16 4 ng/mL units at 3 hours (P
.05) and by 18–16 3 ng/mL at 6 hours of hyperinsulin-
emia (P  .05; Figure 2B). When analyzed by Western
blotting using a previously characterized antibody (12),
no significant changewas detected in the amount ofANG-
PTL8 between the 0-, 3-, and 6-hour time points (Figure
2D). The correlation coefficient between the ANGPTL8
values measured by Western blotting (ANGPTL8/fi-
bronectin) and the ELISA assay was 0.21; P .16. In vivo
hyperinsulinemia decreased plasma ANGPTL4 by 14%
from a fasting concentration of 5.9  0.9 to 5.1  0.7
ng/mL by 3 hours (P  .01) and by 24% to 4.5  0.5
ng/mL (P  .01) by 6 hours (Figure 2C).
Insulin regulation of ANGPTL3 in hepatocytes in
vitro
The insulin-induced decrease of plasma ANGPTL3
could have resulted from down-regulation of gene expres-
sion in the liver.When studied in IHHcells in vitro, insulin
decreased ANGPTL3mRNA expression 3.2-fold (Figure
3A). After 24-hour incubation of IHH, most ANGPTL3
was found secreted into the serum-free growthmedium.A
minor portion was recovered in the cellular fraction (Fig-
ure 3D). Secretion of ANGPTL3 into IHH growth me-
dium decreased significantly by 18% and the cellular pro-
tein by 25%upon insulin treatment (Figure 3D). Thus, the
insulin-induced 26–38% decreases in human plasma
could have resulted from insulin inhibition of ANGPTL3
production in the liver.
Insulin regulation of ANGPTL8 in adipose tissue
and hepatocytes in vitro
Reanalysisofmicroarraydata (27) showed thatANGPTL8
was induced 32-fold by in vivo hyperinsulinemia and
was the single most insulin-responsive transcript in hu-
man adipose tissue (Table 1). The insulin-induced de-
crease (ELISA) or unchanged concentration (Western
blotting) of plasma ANGPTL8 could have been a con-
Figure 1. Expression of ANGPTL mRNAs in liver and sc adipose tissue. Relative ANGPTL3 (A), ANGPTL8 (B), and ANGPTL4 (C) mRNA
concentrations in the liver and sc adipose tissue (AT) from 34 subjects. The data represent mean  SEM; n  34; ***, P  .001, liver vs sc adipose
tissue.
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sequence of insulin action on gene expression in adipose
tissue or the liver. To examine this possibility, sc adipose
tissue biopsies were collected at 0, 3, and 6 hours of insulin
infusion, andANGPTL8mRNAexpressionwas quantified
by qPCR. In vivo hyperinsulinemia strikingly induced adi-
pose tissueANGPTL8geneexpressionby14-and18-foldat
3 and 6 hours (Figure 4A). ANGPTL4 gene expression de-
creasedby23and51%by3and6hoursofhyperinsulinemia
compared with the 0-hour time point (Figure 4B).
Given that the effect of in vivo hyperinsulinemia on
ANGPTL8 gene expression in adipose tissue might be
indirect and mediated by changes in circulating metabo-
lites such as free fatty acids, we examined effects of insulin
on ANGPTL8 gene expression in vitro in SGBS adi-
pocytes. Insulin increased ANGPTL8 mRNA concentra-
tion 10-fold (Figure 3C) and the cellular ANGPTL8 pro-
tein by 32% (Figure 3F). ANGPTL8 accumulated inside
the cells, as no ANGPTL was detectable in the medium
(Figure 3F). These data imply that, although insulinmark-
edly increases ANGPTL8 locally in adipocytes, this action
of insulin does not contribute to circulating ANGPTL8
concentrations.
To determine whether the observed small decrease in
circulating ANGPTL8 concentrations (ELISA assay) was
due to insulin action in the liver, we
studied the effects of insulin on
ANGPTL8 gene expression in IHH.
Insulin increased ANGPTL8 gene
expression 2.2-fold in response to
24-hour treatment (Figure 3B), and
the intracellular ANGPTL8 protein
by 19% (Figure 3E), but only a neg-
ligible amount of ANGPTL8 protein
was found in culture medium. These
data show that insulin increases
ANGPTL8 locally not only in adi-
pose tissue but also in IHH and that
this effect does not seem to contrib-
ute to extracellular/circulating con-
centrations of the protein.
ANGPTL3 promotes secretion of
ANGPTL8 by stably transfected
CHO cells
TodeterminewhetherANGPTL3
modulates secretion of ANGPTL8,
we created stably transfected CHO
cells overexpressing ANGPTL3, -8,
or both. Cells expressing ANGPTL8
alone were not able to secrete the
protein, which accumulated in the
cellular fraction as determined by
Western blotting (Figure 5).Cells ex-
pressing ANGPTL3 alone secreted this protein abun-
dantly into medium. Abundant secretion of ANGPTL8
into the culture medium was found in cells coexpressing
ANGPTL3 and -8 (Figure 5), demonstrating that ANG-
PTL3 promotes secretion of ANGPTL8 in CHO cells. A
similar result was obtained using the ELISA assays (data
not shown). These data are consistent with those reported
in HepG2 cells (12), and raise the possibility that the de-
crease in ANGPTL8 (ELISA assay) was a consequence of
the decrease in hepatic ANGPTL3 expression by insulin.
Discussion
We examined whether and how insulin regulates circulat-
ing ANGPTL3 and -8 concentrations and whether
changes in their circulating concentrations reflect insulin
action in adipose tissue and the liver. Measurement of
plasma ANGPTL4 was included to verify that its plasma
levels respond to insulin as has been reported. To this end,
wemeasured circulatingANGPTL3and -8 concentrations
and their expression in human adipose tissue biopsies be-
fore and after 3 and 6 hours of in vivo euglycemic hyper-
Figure 2. Effect of insulin on human plasma ANGPTL3, -8 and -4 concentrations in vivo. Plasma
ANGPTL3 (A), ANGPTL8 (B), and ANGPTL4 (C) concentrations at 0, 3, and 6 h of insulin infusion
in human subjects. The data represent mean  SEM; n  18; *, P  .05; **, P  .01; ***, P 
.001, difference vs 0 hours. Western blots showing plasma ANGPTL8 in nine subjects after 0, 3,
and 6 h of insulin infusion (D). The plasma protein fibronectin was used as a loading control.
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insulinemia. To explain the observed changes in vivo, ef-
fects of insulin on ANGPTL3 and -8 gene and protein
expression were examined in vitro in IHH and SGBS cells
as well as in stably transfected CHO cells overexpressing
ANGPTL3, -8, or both.
The present data are novel in showing that insulin de-
creases plasma ANGPTL3 concentrations in vivo in hu-
mans. This decrease is likely to reflect insulin action in the
liver. Analysis of paired adipose tissue and liver samples in
the present study confirmed that ANGPTL3 is not ex-
pressed in human adipose tissue but is found in the liver
(8). In IHH cells insulin decreased ANGPTL3 gene and
protein expression. These data are consistent with a pre-
vious report showing that insulin down-regulates ANG-
PTL3mRNAand protein expression in human hepatoma
HepG2 cells (23).ANGPTL3mRNA and protein expres-
sion were also reported to be increased in the liver of STZ
mice and this increase was attenuated by insulin (31).
Figure 3. Effect of insulin on ANGPTL3 and -8 mRNA and protein expression in cultured IHH and SGBS adipocytes. Relative mRNA concentration
of ANGPTL3 and -8 in control and insulin-treated cultured IHH (A and B). mRNA expression of ANGPTL8 in control and insulin-treated SGBS
adipocytes (C). ANGPTL3 and ANGPTL8 protein concentrations in culture medium (Medium) and cell lysates (Cells) of control and insulin-treated
IHH (D and E). ANGPTL8 protein concentrations in culture media and cell lysates of control and insulin-treated SGBS adipocytes (F). The data
represent mean  SEM (n  6); *, P  .05; **, P  .01; ***, P  .001. The inset in panel F shows a Western blot of the SGBS adipocyte
supernatants from unstimulated (i) and insulin stimulated (i) cells, probed for adiponectin.
Table 1. Effect of Insulin on Gene Expression (Microarray Analysis) in Human Adipose Tissue Biopsies
mRNA Description
Fastinga
Expression
Insulin-Stimulated
Expression
Nominal
P Value
Fold Induction
by Insulin
ANGPTL8 Angiopoietin-like 8 84 2719 9.3E-04 32.2
NFIL3 Nuclear factor, IL-3 regulated 185 1811 9.0E-03 9.8
PNPLA3 Patatin-like phospholipase domain containing 3 93 757 4.9E-05 8.1
INSIG1 Insulin induced gene 1 510 3494 2.8E-02 6.8
TMEM70 Transmembrane protein 70 239 1439 1.8E-02 6.0
ACLY ATP citrate lyase 832 4966 1.8E-02 6.0
KIAA0040 KIAA0040 72 407 1.2E-02 5.6
APOC1 Apolipoprotein C-I 338 1889 2.7E-02 5.6
FAM49A Family with sequence similarity 49, member A 95 426 7.2E-03 4.5
THRSP Thyroid hormone responsive 5685 25 295 2.9E-04 4.4
The biopsies were taken before (fasting) and after 3 h (insulin-stimulated) of in vivo euglycemic hyperinsulinemia in 5 normal subjects. Relative
expression of the 10 most insulin-induced genes are listed.
a Arbitrary normalized intensity value from gene expression array.
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Plasma ANGPTL8 concentrations decreased slightly
but significantly during euglycemic hyperinsulinemia
when measured by ELISA, although no consistent change
was detected byWestern blotting. Although the antibody
used in the Western blot has been validated previously
(12), the semiquantitative nature of this technique does
not allow detection of small changes. Lack of an increase
in circulating ANGPTL8 in vivo is consistent with the in
vitro data measuring ANGPTL8 in cells and culture me-
dium in response to insulin. Neither in the study of Ren et
al (9) in 3T3-L1 adipocytes nor in the present study in
SGBS cells was insulin able to induce secretion of ANG-
PTL8 into culture media, implying that adipocytes do not
contribute to circulating ANGPTL8. In IHH, insulin in-
creased ANGPTL8 mRNA and protein concentrations
but again the protein accumulated intracellularly with
only a tiny amount being detected in culture media. The
possibility thatplasmaANGPTL8concentrationuponhy-
perinsulinemia is affected by the decreased expression of
ANGPTL3 is discussed below.
Lack of an increase in plasma ANGPTL8 was in strik-
ing contrast with effects of insulin on ANGPTL8 in both
adipose tissue in vivo and in SGBS cells. Indeed, reanalysis
of microarray data from five normal subjects (27) showed
that ANGPTL8 (previously identified as LOC55908 in
Additional File 4 of this reference) was the most insulin-
responsive transcript (32-fold increase) of all genes exam-
ined in human sc adipose tissue. When measured with
qPCR in a larger group of subjects,ANGPTL8 expression
was induced 14- and 18-fold at 3 and 6 hours, which is in
accord with the studies in 3T3-L1 adipocytes (9). The in-
crease in the ANGPTL8 transcript was also observed in
human SGBS adipocytes in the present study and was ac-
companied by an increase in cell-associated ANGPTL8
protein. We analyzed the 500-bp proximal promoter re-
gion of both ANGPTL8 and -3, and found both positive
(CGCCTC) (32) and negative (T(A/G)TTT) (33) insulin-
responsive elements in ANGPTL8. However, only nega-
tive insulin-responsive DNA elements were observed in
ANGPTL3, consistentwith theobservednegative effectof
insulin on the expression of this gene/protein.
ANGPTL8 remained intracellular also when overex-
pressed inCHOcells, but coexpression ofANGPTL3 and
-8 induced secretionof the recombinantANGPTL8.These
data are similar to those in mice in which overexpression
of both ANGPTL3 and -8 but neither cDNA alone in-
duces hypertriglyceridemia (12). The molecular mecha-
nism underlying the interaction between ANGPTL3 and
-8 is beyond the scope of the present study. Hypotheti-
cally, ANGPTL8 may adopt a transport competent con-
formation in the endoplasmic reticulum only when it in-
teracts with another, fibrinogen-like domain containing
ANGPTL, andmay in the absence of the latter be retained
by the endoplasmic reticulum quality control apparatus
(34, 35). One might thus hypothesize that the decrease in
ANGPTL3 in hepatocytes by insulin could have contributed
to the decrease in circulating ANGPTL8 concentrations.
Plasma ANGPTL8 concentrations have recently been
measured in several studies and suggested to be biomark-
ers for both type 2 (14–17, 36) and type 1 (37) diabetes,
obesity (36), hypercholesterolemia (18), as well as insulin
resistance (17). The results have been variable and sug-
gested eg, in obesity either increased (36), unchanged (18)
or decreased (15) concentrations. The present data do not
exclude the possibility that plasma ANGPTL8 measure-
ments could be useful markers of metabolic abnormalities
but suggest that circulating ANGPTL8 concentrations do
Figure 4. Insulin induced expression of ANGPTL mRNAs in sc adipose
tissue. ANGPTL8 (A) and ANGPTL4 (B) mRNA expression in human sc
adipose tissue before and after 3 and 6 hours’ in vivo
hyperinsulinemia. *, P  .05; **, P  .01; ***, P  .001, difference
compared with the 0-h time point. The data represent mean  SEM
from 18 subjects.
Figure 5. Secretion of ANGPTL8 from CHO cells in the presence of
ANGPTL3. Culture media (M) and cellular fractions (C) of CHO cells
stably transfected with ANGPTL3, -8, or both, were analyzed by
Western blotting using ANGPTL8 and -3 antibodies. Mobilities of
molecular mass markers are shown on the left. For ANGPTL8, the
culture media and cell lysates were loaded in equal proportion. Due to
robust secretion of the overexpressed ANGPTL3, culture media loading
for the anti-ANGPTL3 blot is one tenth of that used for the other
medium and cell specimens. A coomassie-stained gel showing sample
loading for the ANGPTL8 blot is depicted at the bottom.
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not mirror insulin action in either the liver or adipose
tissue.
We conclude that insulin acutely decreases circulating
ANGPTL3 in humans. This seems to be a consequence of
insulin inhibition of ANGPTL3 gene expression in the
liver. Insulin markedly up-regulates ANGPTL8 both in
human adipose tissue in vivo and in SGBS cells and IHH
in vitro. However, plasma concentrations of ANGPTL8
donot increase in response to insulin, implying that insulin
action on circulating ANGPTL8 does not reflect its action
in adipose tissue or the liver.
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